biospecimen__admin__batch_number	327.54.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	84A8892B-36E4-4FC4-BDC5-F10E8DB67C33
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-MI-A75G-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-MI-A75G-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-MI-A75G-01A
biospecimen__bio__biospecimen_barcode_bottom	0153879961
biospecimen__bio__day_of_creation	13
biospecimen__bio__day_of_shipment	25
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	08
biospecimen__bio__month_of_shipment	09
biospecimen__bio__pathology_report_file_name	TCGA-MI-A75G.30FAEBBF-0EEE-40F5-9463-50FDDE258D4B.pdf
biospecimen__bio__plate_column	2
biospecimen__bio__plate_id	A32J
biospecimen__bio__plate_row	F
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-MI-A75G
biospecimen__shared__patient_id	A75G
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	0CBF6C03-9A48-4990-B6EC-360A5207910B
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	2.3
clinical__chol_lihc_shared__albumin_result_upper_limit	4.9
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	1.7
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.5
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	9
clinical__chol_lihc_shared__fetoprotein_outcome_value	6
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis C
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	63
clinical__clin_shared__bcr_followup_barcode	TCGA-MI-A75G-F58603
clinical__clin_shared__bcr_followup_uuid	5D08E603-3352-4F32-8E91-07DEDF5051AD
clinical__clin_shared__cancer_first_degree_relative	1
clinical__clin_shared__day_of_form_completion	28
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	11
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	160
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	HCV Genotype
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	a5fa1852-b545-4adf-82d9-1dbf7ffadb9d
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-MI-A75G-01A-11R-A32J-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	803136a6-9ee1-422f-9a2a-bddb608e747b
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.88
gdc__analytes__analyte_id	1c823ea2-8e09-4b11-9851-1cb4c952a707
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	22dd3876-1f2c-4ddd-8fae-f5fb820993ba
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:34:57.516354-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	b7b1e785-bf8f-506a-b7fa-f512d90c296f
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1949
gdc__diagnoses__age_at_diagnosis	23284
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-23284.0
gdc__diagnoses__days_to_last_follow_up	698.0
gdc__diagnoses__diagnosis_id	2172ef4d-2dc1-537d-a1ea-f2602358086a
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	21.777553339224845
gdc__exposures__exposure_id	53a2a0d4-60cb-5f61-8329-6b76b5923966
gdc__exposures__height	178.0
gdc__exposures__weight	69.0
gdc__file_id	c64e50ab-764d-4546-86f2-61ca35edaa45
gdc__file_name	c0d60dd9-776e-4c40-8898-179e14d597a4.mirbase21.mirnas.quantification.txt
gdc__file_size	50282
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	2f9c648a721460dce072273f1d46bf34
gdc__portions__is_ffpe	false
gdc__portions__portion_id	c33ccda2-f8fc-40bd-b6f8-a86b7a700012
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	427
gdc__samples__initial_weight	80.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	30FAEBBF-0EEE-40F5-9463-50FDDE258D4B
gdc__samples__sample_id	688494f9-f573-4d02-a4a1-11341076e1fb
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	2.0
gdc__slides__percent_necrosis	8.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	5.0
gdc__slides__percent_tumor_cells	87.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	f6c3bfdb-80e2-4e4c-921b-73b28ee44ccd
gdc__submitter_id	mirna_swap_dr11_184_MirnaExpression7f8702cc-1826-473d-ac05-a7303cb933d9_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	MI
gdc__tissue_source_site__name	BLN - Baylor
gdc__tissue_source_site__tissue_source_site_id	2b1c1097-fa63-5d15-b5d3-c54f5eacb9c8
gdc__treatments__treatment_id	d851b88e-9d58-57dd-a5ca-a255d0690744
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:22.867+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a5fa1852-b545-4adf-82d9-1dbf7ffadb9d-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/a5fa1852-b545-4adf-82d9-1dbf7ffadb9d-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129653
manually_curated__local_md5	52a5514911b9f685e18cee13917749ee
manually_curated__opengdc_download_date	2018-10-16T17:10:59.000890+02:00
manually_curated__opengdc_file_md5	e0dd653b7432cec28dc1c6f3bac07f53
manually_curated__opengdc_file_size	50281
manually_curated__opengdc_id	a5fa1852-b545-4adf-82d9-1dbf7ffadb9d-meq
manually_curated__origin_file_size	129653
manually_curated__origin_last_modified_date	Tue Oct 16 18:08:00 CEST 2018
manually_curated__origin_md5	52a5514911b9f685e18cee13917749ee
manually_curated__tissue_status	tumoral
